tiprankstipranks
Blurbs

Analysts Offer Insights on Healthcare Companies: Doximity (DOCS), Innate Pharma (IPHA) and Shockwave Medical (SWAV)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Doximity (DOCSResearch Report), Innate Pharma (IPHAResearch Report) and Shockwave Medical (SWAVResearch Report).

Doximity (DOCS)

Truist Financial analyst Jailendra Singh maintained a Hold rating on Doximity on October 20 and set a price target of $28.00. The company’s shares closed last Tuesday at $22.82, close to its 52-week low of $19.71.

According to TipRanks.com, Singh has 0 stars on 0-5 stars ranking scale with an average return of -15.8% and a 28.9% success rate. Singh covers the Healthcare sector, focusing on stocks such as Privia Health Group, NextGen Healthcare, and Hims & Hers Health.

Currently, the analyst consensus on Doximity is a Hold with an average price target of $25.89, which is a 15.2% upside from current levels. In a report issued on October 11, Evercore ISI also maintained a Hold rating on the stock with a $21.00 price target.

See the top stocks recommended by analysts >>

Innate Pharma (IPHA)

Leerink Partners analyst Daina Graybosch maintained a Buy rating on Innate Pharma on October 23. The company’s shares closed last Tuesday at $2.60.

According to TipRanks.com, Graybosch has 0 stars on 0-5 stars ranking scale with an average return of -27.2% and a 21.5% success rate. Graybosch covers the Healthcare sector, focusing on stocks such as Turnstone Biologics Corp., Werewolf Therapeutics, and Bolt Biotherapeutics.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Innate Pharma with a $9.75 average price target.

Shockwave Medical (SWAV)

Leerink Partners analyst Mike Kratky maintained a Buy rating on Shockwave Medical yesterday and set a price target of $263.00. The company’s shares closed last Tuesday at $214.53.

According to TipRanks.com, Kratky is a 1-star analyst with an average return of -8.5% and a 16.0% success rate. Kratky covers the Healthcare sector, focusing on stocks such as Axonics Modulation Technologies, Inspire Medical Systems, and Edwards Lifesciences.

Currently, the analyst consensus on Shockwave Medical is a Moderate Buy with an average price target of $261.20, implying a 28.9% upside from current levels. In a report issued on October 18, Bank of America Securities also maintained a Buy rating on the stock with a $250.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on DOCS:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles